Evidence map›Paper›PMID 38503815›Full record

ArticleScientific reports2024

Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms.

Rhian Stavely, Ainsley M Robinson, Sarah Fraser, Rhiannon T Filippone, Vanesa Stojanovska, Rajaraman Eri, Vasso Apostolopoulos, Samy Sakkal, Kulmira Nurgali

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. HMGB1: key mediator in digestive system diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Alterations in tryptophan metabolism andFrontiers in medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Rhian StavelyInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Ainsley M RobinsonInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Sarah FraserInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Rhiannon T FilipponeInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Vanesa StojanovskaInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Rajaraman EriSchool of Science, STEM College, RMIT University, Melbourne, VIC, Australia.
Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Samy SakkalInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia.
Kulmira NurgaliInstitute for Health and Sport, Victoria University, Melbourne, VIC, Australia. kulmira.nurgali@vu.edu.au.
Victoria University · AUAustralian Institute for Musculoskeletal Science · AUHarvard University · USRMIT University · AUThe University of Melbourne · AU

Funding

Australian National Health and Medical Research Council (NHMRC) GNT1158952Crohn's & Colitis Foundation Senior Research Award 903433Victoria University Collaborative Research Grant Scheme VU CRGS 13-16
6 · The paper itself

Abstract

Current treatments for inflammatory bowel disease (IBD) are often inadequate due to limited efficacy and toxicity, leading to surgical resection in refractory cases. IBD's broad and complex pathogenesis involving the immune system, enteric nervous system, microbiome, and oxidative stress requires more effective therapeutic strategies. In this study, we investigated the therapeutic potential of bone marrow-derived mesenchymal stem cell (BM-MSC) treatments in spontaneous chronic colitis using the Winnie mouse model which closely replicates the presentation and inflammatory profile of ulcerative colitis. The 14-day BM-MSC treatment regimen reduced the severity of colitis, leading to the attenuation of diarrheal symptoms and recovery in body mass. Morphological and histological abnormalities in the colon were also alleviated. Transcriptomic analysis demonstrated that BM-MSC treatment led to alterations in gene expression profiles primarily downregulating genes related to inflammation, including pro-inflammatory cytokines, chemokines and other biomarkers of inflammation. Further evaluation of immune cell populations using immunohistochemistry revealed a reduction in leukocyte infiltration upon BM-MSC treatment. Notably, enteric neuronal gene signatures were the most impacted by BM-MSC treatment, which correlated with the restoration of neuronal density in the myenteric ganglia. Moreover, BM-MSCs exhibited neuroprotective effects against oxidative stress-induced neuronal loss through antioxidant mechanisms, including the reduction of mitochondrial-derived superoxide and attenuation of oxidative stress-induced HMGB1 translocation, potentially relying on MSC-derived SOD1. These findings suggest that BM-MSCs hold promise as a therapeutic intervention to mitigate chronic colitis by exerting anti-inflammatory effects and protecting the enteric nervous system from oxidative stress-induced damage.

Indexed as

ColitisInflammatory Bowel DiseasesIntestinal Pseudo-ObstructionMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsAnti-Inflammatory AgentsBone MarrowDisease Models, AnimalInflammationMiceAnti-Inflammatory AgentsBM-MSCColitisEnteric nervous systemMesenchymal stem cellNeuroinflammationOxidative stress

Identifiers

PMID38503815
PMCPMC10951223
OpenAlexW4393012719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.